Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Non-Current Debt (2023 - 2025)

Sanara MedTech's Non-Current Debt history spans 5 years, with the latest figure at $46.0 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 49.79% year-over-year to $46.0 million; the TTM value through Dec 2025 reached $46.0 million, up 49.79%, while the annual FY2025 figure was $46.0 million, 49.79% up from the prior year.
  • Non-Current Debt reached $46.0 million in Q4 2025 per SMTI's latest filing, up from $536883.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $46.0 million in Q4 2025 to a low of $536883.0 in Q3 2025.
  • Average Non-Current Debt over 3 years is $13.9 million, with a median of $8.9 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: surged 236.76% in 2024, then plummeted 98.21% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $9.1 million in 2023, then soared by 236.76% to $30.7 million in 2024, then surged by 49.79% to $46.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Non-Current Debt are $46.0 million (Q4 2025), $536883.0 (Q3 2025), and $1.1 million (Q2 2025).